Catalyst Wire Dossier Catalyst Wire Dossier

trifluridine/tipiracil

trifluridine/tipiracil · Taiho Oncology
Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for trifluridine/tipiracil, covering 2020-11-17 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) [Phase 3]

See pricing